No-Liquidity VC Deals: SAFE Side Letters and ROFRs

The new normal: control without a priced round

There’s a quiet shift happening in early-stage venture financing, and it’s easy to miss because it rarely shows up in headline numbers or market reports.

The classic story of venture funding, term sheet → priced preferred round → board seat → pro rata rights → clear governance, is being replaced, especially at pre-seed and seed, by something more ambiguous: SAFEs plus side letters, bundled with ROFRs, transfer restrictions, MFN clauses, and a handful of bespoke “add-ons” that collectively give investors many of the protections and ownership lock-in of a priced round, without actually pricing the round.

Founders often interpret this as “lighter weight” financing. Some investors pitch it as “founder-friendly,” “faster,” or “standard.” In practice, these “no-liquidity” deals can create a different kind of friction: not the overt friction of negotiation at a priced round, but the creeping friction of hidden governance and liquidity constraints that can make later financings harder, constrain employee liquidity, and shift leverage to early investors when it matters most.

This article is opinionated: these structures are not inherently bad, but they are often used in ways that are asymmetric: protecting investors while quietly reducing founder optionality. The right response isn’t panic. It’s literacy and negotiation.

What “no-liquidity” deals really mean

The phrase “no-liquidity VC deals” isn’t a formal legal category. It’s a descriptive shorthand for a pattern:

The company raises money on SAFEs (or convertible instruments) rather than a priced equity round.

Investors seek equity-like protections and lock-ups through side letters and SAFE addenda.

The company has no near-term plan (or ability) to price the round, and the instrument can remain outstanding for a long time.

The “no-liquidity” label comes from the reality that these instruments often delay the moment when anyone has clean, transferable shares, while still enabling investors to control or constrain transfers and future issuance.

Why it’s happening now

Several forces have converged:

The post-2021 reset: With less competition for deals, investors can ask for more downside protections.

Longer time to Series A: Companies might sit in “seed limbo” for 18–36 months. SAFEs that were meant to be temporary become quasi-permanent.

Standardization of SAFEs: YC’s SAFE made raising easier, but it also created a widely accepted base document that can be modified quietly.

Secondary markets and founder/employee liquidity: As secondary became more common, more investors started adding restrictions to prevent “cap table chaos.”

To be clear: many of these investor concerns are legitimate. The issue is how they are implemented, often off the cap table’s “main stage” where founders are used to negotiating.

SAFEs were designed to be simple. Side letters make them complex.

A SAFE (Simple Agreement for Future Equity) was designed to reduce negotiation overhead by deferring valuation and many preferred stock terms until a priced equity financing.

Key point: a SAFE is not equity today. It’s a contract right to receive equity in the future upon specified triggers.

The simplicity breaks down when investors add side letters or “SAFE add-ons” that effectively recreate priced-round features:

Information rights that resemble major investor rights

Pro rata rights that behave like preemptive rights

MFN clauses that re-open negotiations later

ROFRs and transfer restrictions that lock up future liquidity

Consent rights over future financings or secondary transfers

The result is a hybrid instrument: a SAFE with term-sheet gravity.

The key tools: what investors are adding (and why)

Below are the most common “quiet” terms, what they do, and why investors want them.

1) Side letters: the stealth term sheet

A side letter is a separate agreement between the company and an investor that grants rights not contained in the base SAFE.

Common side-letter rights include:

Information rights: financial statements, budgets, monthly updates

Inspection rights: ability to visit offices, review books

Pro rata rights: right to buy a percentage of the next round

Most-favored-nation (MFN): ability to adopt later investors’ better terms

Board observer rights (sometimes)

Consent rights over certain corporate actions

Why investors like them:

They’re faster than negotiating a priced round.

They create differentiation among investors (“we get special access”).

They give investors leverage later, especially if the company is capital constrained.

Why founders should care:

Side letters can create a fragmented rights landscape. Two investors on identical SAFEs may have materially different control.

They can become de facto “major investor” rights long before a priced round.

They can complicate diligence at Series A (new lead investors will ask: who has what rights?).

Reference: YC SAFE forms and commentary (for baseline SAFE concept and typical triggers): https://www.ycombinator.com/documents

2) MFN clauses: the term that negotiates itself

An MFN (most favored nation) clause typically gives the investor the right to upgrade their SAFE terms if the company later issues SAFEs with more favorable terms.

MFNs can be limited (e.g., only economic terms like valuation cap/discount) or broad (including side-letter rights).

Investor rationale:

Protect against being “early but punished.”

Reduce fear of overpaying relative to later investors.

Founder risk:

MFNs can create a “ratchet effect.” A single concession to one later investor can cascade backward.

MFNs can kill flexibility in creative financings (e.g., strategic SAFE with special terms).

A founder-friendly framing is: MFN is not evil, but it should be narrow, time-bound, and clear about scope.

3) ROFRs (Right of First Refusal): controlling the secondary market

A ROFR gives a party (often the company, sometimes the investors) the right to purchase shares before they are sold to a third party.

ROFRs are extremely common in venture-backed companies, especially in stock purchase agreements and investor rights agreements in priced rounds.

The twist in “no-liquidity” SAFE deals is that ROFR-like provisions show up earlier via:

Side letters promising ROFRs upon conversion

Transfer restrictions that apply to founder shares now (or to future issuances)

Contractual commitments that any secondary sale requires investor consent

Investor rationale:

Avoid “undesirable” parties on the cap table.

Control information leakage.

Reduce price signaling from secondaries.

Founder/employee risk:

It can effectively block legitimate secondary liquidity, even small sales for tax payments or life events.

It can create a perception of illiquidity that makes hiring harder.

Reference: NVCA model legal documents (illustrative baseline of ROFR/co-sale constructs in priced rounds): https://nvca.org/model-legal-documents/

4) Transfer restrictions: a blunt instrument

Transfer restrictions can include:

Prohibitions on transfers without board/investor approval

Limits on who can hold shares (accredited-only, no competitors)

Lock-ups extending beyond typical vesting and repurchase rights

Some restrictions are reasonable, particularly to preserve securities law compliance and cap table hygiene. The problem is when they are drafted to make any secondary practically impossible.

The subtle dynamic: restrictions rarely matter until they matter. When an employee wants to sell a small portion to cover AMT or a founder wants to reduce concentration risk, the paperwork suddenly becomes a leverage point for investors.

5) Pro rata rights via side letters: ownership lock-in without pricing

In priced rounds, pro rata rights are typically granted to “major investors” (definition varies) and documented in the investor rights agreement.

In SAFE rounds, pro rata often appears as:

A side-letter right to participate in the next equity financing

A promise of “super pro rata” (ability to buy more than pro rata)

Investor rationale:

If the company breaks out, pro rata is how funds maintain ownership.

Founder risk:

If too many investors have pro rata, the next lead investor may have less allocation, reducing their incentive.

It can make “cleaning up” the round harder.

There’s a real balancing act here. Many founders want to reward early believers with pro rata. But it should be managed intentionally, not scattered across side letters.

6) Consent rights without preferred stock: governance creep

Some side letters include consent rights like:

Approval required for additional debt

Approval required for issuing securities above a threshold

Approval required for a change in business or budget

In a priced round, these show up as protective provisions for preferred stockholders. In SAFE world, adding them early can create a situation where non-stockholders (SAFE holders) have veto power-like influence.

Whether that’s enforceable depends on drafting and state law, but practically, companies comply because they don’t want litigation or reputational damage in a tight capital market.

Why investors prefer these structures over term sheets

It’s tempting to say investors do this because they’re “sneaky.” The more accurate explanation is structural:

Speed: SAFEs close quickly; term sheets and priced rounds take longer.

Optionality: Investors can get exposure without committing to a valuation.

Downside control: Side letters can reduce risk (information, governance, allocation).

Portfolio math: Funds want to lock in the right to maintain ownership in winners.

Signaling risk avoidance: Pricing a round sets an explicit mark. Some investors prefer to postpone that.

From the investor seat, it’s rational. From the founder seat, it can create hidden costs.

The founder cost: not dilution, friction and leverage

Founders tend to focus on valuation caps and dilution. In “no-liquidity” SAFE deals, the biggest costs often show up elsewhere:

1) Cap table complexity becomes a Series A tax

A Series A lead will diligence:

Every SAFE version

n- Every side letter

Any special rights

Whether any investor has blocking rights or unusual transfer controls

The more bespoke paperwork, the more time and legal cost. Worse, it can introduce “deal risk” if the lead investor demands cleanup.

2) Liquidity constraints can hurt hiring and retention

Senior hires increasingly ask about:

Secondary sale opportunities

Exercise/tax planning support

Whether the company historically allows liquidity windows

If early investors have strong ROFRs or consent rights that effectively block secondary, you may be less competitive in talent markets.

3) The “shadow priced round” problem

When enough side-letter rights accumulate, you’ve recreated a priced-round governance structure, without the clarity of a priced round.

That ambiguity creates leverage points:

“We’ll waive X if you give us Y.”

“We’ll consent if the round is structured our way.”

A priced round forces everyone to negotiate at once. Side-letter creep forces founders to renegotiate continuously.

4) Misalignment on the path to pricing

If early investors are comfortable sitting on SAFEs with control-ish rights, they may have less urgency to price a round. Founders might want the clarity and signaling of priced equity; investors might prefer indefinite optionality.

Multiple perspectives: when these terms are reasonable

It’s important to acknowledge the legitimate reasons these clauses exist.

Scenario A: Founder wants speed and minimal distraction

A pre-seed company may rationally accept a SAFE with light side-letter info rights to close quickly and build.

Scenario B: Investor is concentrated and needs basic protections

An angel writing a meaningful check may reasonably ask for:

Basic information rights

A narrow MFN

Pro rata in the next round

Scenario C: The company is enabling secondary too early

If a company starts allowing broad secondary sales at seed stage, it can create adverse selection (people who know most sell first) and cap table bloat. Some ROFR and transfer discipline can be healthy.

Scenario D: Regulatory and compliance constraints

Certain transfer restrictions are sensible for securities compliance and to avoid accidental public-market-like behavior.

The critique is not “never agree.” It’s don’t accept a priced-round governance package smuggled into a SAFE without understanding the consequences.

What founders can negotiate (before it’s too late)

If you only remember one thing: the best time to negotiate these rights is before the SAFE is signed. After money is in, leverage changes.

Here are practical negotiation points that preserve founder flexibility without being unreasonable.

1) Standardize your SAFE docs

If possible:

Use one SAFE template.

Avoid multiple versions with slightly different terms.

Keep a clear schedule of investors and their rights.

If an investor wants special rights, try to:

Put them in a standard side letter template used for everyone at that check size.

Or formalize them in a single “Seed SAFE Rights Agreement” rather than bespoke letters.

This is partly legal hygiene, partly fundraising signaling: clean docs build confidence.

2) Narrow MFN scope

Founder-friendly MFN guardrails:

Limit to economic terms (valuation cap and/or discount).

Exclude side letters explicitly.

Time-bound MFN (e.g., applies only to SAFEs issued within 90–180 days).

Exclude strategic financings or grants tied to partnerships.

MFN is often where “small” concessions become future traps.

3) Put pro rata on rails

If you grant pro rata via side letter:

Define what “next financing” means (equity financing above a threshold).

Clarify whether it applies to seed only vs. all future rounds.

Cap it (e.g., pro rata through Series A only).

Avoid “super pro rata” unless you’re intentionally anchoring the round.

Pro rata is valuable. Don’t give it away accidentally or infinitely.

4) Clarify secondary and transfer rules explicitly

Instead of vague consent rights, propose a policy-like structure:

Company has ROFR on founder/employee transfers (common).

Investors have co-sale rights only in defined circumstances (more common in priced rounds).

Pre-approve small secondary sales under clear thresholds (e.g., $25k–$100k per year) for tax planning, subject to compliance.

The goal is to avoid a world where every secondary is a bespoke negotiation.

5) Avoid consent rights that mimic protective provisions

If an investor asks for veto-like rights while still on a SAFE, consider pushback:

Offer information rights instead.

Offer a call/consultation right before major actions.

Offer governance rights only upon conversion in a priced round.

If they insist, narrow the scope and add:

Materiality thresholds

Sunset clauses

Clear definitions

6) Add sunsets to side-letter rights

One of the cleanest solutions: rights that expire.

Examples:

Information rights expire upon the earlier of Series A or 18 months.

MFN expires after the round closes or after a fixed date.

Pro rata applies only through the next priced round.

Sunsets prevent “permanent seed terms.”

7) Use check-size tiers instead of one-off favors

A common founder mistake is granting bespoke rights to win a single investor.

Instead:

Publish (informally) tiers: e.g., over $250k gets pro rata and quarterly financials; over $500k gets monthly updates.

Keep it consistent.

This reduces resentment among investors and reduces future legal entropy.

8) Be careful with “future promises”

Some side letters include commitments like:

“Company will not issue more favorable SAFEs.”

“Company will use best efforts to raise a priced round by X date.”

“Company will create an employee liquidity program.”

These can become enforceable obligations or at least strong leverage points. If you must agree, ensure terms are:

Clearly defined

Achievable

Not open-ended

Red flags that you’re recreating a term sheet (badly)

Not all side letters are problematic. But founders should slow down when they see:

Broad MFN that includes “any rights granted to any other investor”

Investor consent required for future financings or for issuing equity

Transfer restrictions that apply to employees and founders without clear exceptions

Side-letter rights that are perpetual with no conversion/pricing trigger

Multiple “classes” of SAFE investors with different governance packages

If you’re stacking enough of these, you should ask: why not just price a seed round?

Why term sheets are coming back, in a different way

There’s an irony here: the more SAFEs get loaded with side-letter terms, the more the market drifts back toward term-sheet complexity, just distributed across many documents.

A priced seed round has costs (time, legal fees, negotiation), but it also has benefits:

Clear governance

Clear major investor definitions

Clear protective provisions

Standard NVCA-style document sets (in later stages)

In some cases, the “founder-friendly” option is actually to price the round earlier, because it forces clarity and prevents perpetual convertibles with creeping controls.

Practical advice for founders running a SAFE round

Here’s a pragmatic playbook if you’re raising on SAFEs and want to avoid the worst “no-liquidity” outcomes.

Step 1: Decide your philosophy on secondary early

Write down internally:

Will you allow any founder/employee liquidity before Series A?

Under what circumstances?

Who approves it?

If you don’t decide, your earliest investors will decide for you through restrictions.

Step 2: Build a rights matrix

Create a simple table:

Investor name

SAFE cap/discount

MFN? scope?

Pro rata? through when?

Info rights? frequency?

Any consent/transfer rights?

This is invaluable for later diligence and helps you spot inconsistencies.

Step 3: Prefer one “clean” side letter template

Draft one side letter template with counsel and stick to it. Deviations should be rare and deliberate.

Step 4: Make the next lead’s life easy

Ask: If I were a Series A lead, would I hate this cap table?

If the answer is yes, you will eventually pay for it, either in legal cleanup, lost time, or reduced leverage.

What investors should do (if they want to be good partners)

The best investors can still protect themselves without creating cap table landmines.

Constructive investor behaviors:

Keep MFN narrow and time-limited.

Avoid governance creep on SAFEs; reserve strong controls for priced rounds.

Standardize side letters rather than bespoke demands.

Be explicit about secondary policy rather than using ambiguity as leverage.

Investors who take the opposite approach may win more rights early, but they can also poison later rounds if new leads view the structure as messy or coercive.

Legal and market references (for further reading)

YC SAFE documents (baseline SAFE forms and concepts): https://www.ycombinator.com/documents

NVCA Model Legal Documents (typical priced-round constructs like ROFR/co-sale and investor rights): https://nvca.org/model-legal-documents/

SEC overview of private offerings (Reg D) (context for why transfer restrictions and accredited investor concerns exist): https://www.sec.gov/smallbusiness/exemptofferings

Carta resources on SAFEs and fundraising mechanics (market education; not authoritative law): https://carta.com/learn/

(As always: these are educational references, not legal advice.)

The bottom line

SAFEs are not the problem. Side letters are not the problem. ROFRs and transfer restrictions are not the problem.

The problem is the unpriced, indefinite, rights-heavy financing stack: a set of documents that delays valuation and liquidity while steadily importing control features, creating a cap table that is constrained but not clean.

If you’re a founder, the correct posture is neither paranoia nor passivity. It’s to treat every “small” add-on as part of an emerging governance system. Negotiate for:

standardization (fewer bespoke documents),

clarity (explicit policies on secondary and pro rata),

limits (narrow MFN, materiality thresholds), and

sunsets (rights that expire or convert into priced-round norms).

Do that, and you can keep the speed benefits of SAFEs without waking up a year later to discover you effectively signed a term sheet, one clause at a time.